The Health Technology Assessment landscape is changing in the EU – soon a single standardised assessment will be used across all member states. January 2022
Many market access decisions were intended to provide rapid one-off answers to one of the most extraordinary situations healthcare systems have ever had to face, but some of them are telling us something about the more profound changes that are likely to affect pharmaceutical market access in the longer run.